Grand Rounds| Volume 78, ISSUE 3, P505-507, September 2011

A 72-Year-old Male With Left Testicular Pain

      A 72-year-old men presented to his primary care physician with a chief complaint of a painful left scrotal mass of 2 weeks' duration. He had a medical history of noninvasive bladder cancer for which he had completed a 6-week induction course of bacille Calmette-Guérin (BCG) 5 months before his present presentation. During his treatment, other than mild dysuria, he did not recall any scrotal discomfort, fever, or chills. The urine cultures were negative; however, the patient was treated with a 2-week course of ciprofloxacin antibiotics and nonsteroidal anti-inflammatory drugs. During his urologic consultation, the left scrotum was erythrematous, and an indurated mass was palpable at the lower pole of the left testis involving the epididymis, which had not decreased in size. He denied dysuria, hematuria, fevers, chills, nausea, vomiting, weight loss, or changes in bowel movements. He denied any history of urinary tract infections or other genitourinary complaints. Recent routine blood test results, including hemoglobin, hematocrit, liver function tests, α-fetoprotein, human chorionic gonadotropin, and lactate dehydrogenase, were within normal limits. His urinalysis revealed microscopic hematuria and was otherwise unremarkable. The urine culture was negative.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Urology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Sylvester R.J.
        • van der Meijden A.P.
        • Lamm D.L.
        Intravesical bacillus Calmette-Guérin reduces the risk of progression in patients with superficial bladder cancer: a meta-analysis of the published results of randomized clinical trials.
        J Urol. 2002; 168: 1964-1970
        • Takeda T.
        • Kikuchi E.
        • Yuge K.
        • et al.
        Discontinuance of bacille Calmette-Guérin instillation therapy for nonmuscle-invasive bladder cancer has negative effect on tumor recurrence.
        Urology. 2009; 73: 1318-1322
        • Videira P.A.
        • Calais F.M.
        • Correia M.
        • et al.
        Efficacy of bacille Calmette-Guérin immunotherapy predicted by expression of antigen-presenting molecules and chemokines.
        Urology. 2009; 74: 944-950
        • Lamm D.L.
        Efficacy and safety of bacilli Calmette-Guérin immunotherapy in superficial bladder cancer.
        Clin Infect Dis. 2000; 31: 86-90
        • Yang D.M.
        • Yoon M.H.
        • Kim H.S.
        • et al.
        Comparison of tuberculous and pyogenic epididymal abscesses: clinical, gray-scale sonographic, and color Doppler sonographic features.
        AJR Am J Roentgenol. 2001; 177: 1131-1135
        • Muttarak M.
        • Peh W.C.
        • Lojanapiwat B.
        • Chaiwun B.
        Tuberculous epididymitis and epididymo-orchitis: sonographic appearances.
        AJR Am J Roentgenol. 2001; 176: 1459-1466
        • Wilson D.L.
        • Watson R.A.
        • Al-Dulaimi H.
        • et al.
        Tuberculous epididymitis with abscess formation after intravesical bacillus Calmette-Guérin instillation.
        Infect Urol. 2001; 14: 3-9
        • Falkensammer C.
        • Gozzi C.
        • Hager M.
        • et al.
        Late occurrence of bilateral tuberculous-like epididymo-orchitis after intravesical bacille Calmette-Guérin therapy for superficial bladder carcinoma.
        Urology. 2005; 65: 175
        • Nawgiri R.
        • Onel E.
        • Dayal Y.
        Granulomatous epididymo-orchitis related to BCG therapy.
        Infect Urol. 2002; 15: 17-20